Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cardiovascular Research

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cvr/cvr218PMID 21955554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Role for the Low-Affinity A2B Adenosine Receptor in Regulating Superoxide Generation by Murine Neutrophils

  2011cited by this paper
• Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.

  2011cited by this paper
• 2′-AMP and 3′-AMP Inhibit Proliferation of Preglomerular Vascular Smooth Muscle Cells and Glomerular Mesangial Cells via A2B Receptors

  2011cited by this paper
• NT5E mutations and arterial calcifications.

  2011cited by this paper
• A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1‐dependent cholesterol efflux

  2010cited by this paper
• P2Y receptors and atherosclerosis in apolipoprotein E‐deficient mice

  2010cited by this paper
• Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology

  2010cited by this paper
• Adenosine Receptor A2A Deficiency in Leukocytes Increases Arterial Neointima Formation in Apolipoprotein E–Deficient Mice

  2010cited by this paper
• Immune and inflammatory mechanisms of atherosclerosis (*).

  2009cited by this paper
• Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis.

  2009cited by this paper
• Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells

  2008cited by this paper
• Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL

  2008cited by this paper
• Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

  2008cited by this paper
• Ecto‐5′‐nucleotidase (CD73) ‐mediated extracellular adenosine production plays a critical role in hepatic fibrosis

  2008cited by this paper
• CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis

  2008cited by this paper
• CD73 Participates in Cellular Multiresistance Program and Protects against TRAIL-Induced Apoptosis1

  2008cited by this paper
• Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue-interactions with insulin.

  2008cited by this paper
• Ecto-5′-Nucleotidase Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction

  2008cited by this paper
• Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis.

  2008cited by this paper
• Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

  2007cited by this paper
• Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases.

  2007cited by this paper
• Connexin37 protects against atherosclerosis by regulating monocyte adhesion

  2006cited by this paper
• Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization

  2006cited by this paper
• Physiological roles for ecto-5’-nucleotidase (CD73)

  2006cited by this paper
• Ecto-5'-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo.

  2006cited by this paper
• Alkaline Phosphatases

  2006cited by this paper
• CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation

  2006cited by this paper
• Adenosine receptors as therapeutic targets

  2006cited by this paper
• Ecto-5′-Nucleotidase (CD73)-Mediated Adenosine Production Is Tissue Protective in a Model of Bleomycin-Induced Lung Injury1

  2006cited by this paper
• Centaurin beta1 down-regulates nucleotide-binding oligomerization domains 1- and 2-dependent NF-kappaB activation.

  2006cited by this paper
• Centaurin β1 Down-regulates Nucleotide-binding Oligomerization Domains 1- and 2-dependent NF-κB Activation*

  2006cited by this paper
• The immune response in atherosclerosis: a double-edged sword

  2006cited by this paper
• Adenosine A2A agonists in development for the treatment of inflammation

  2005cited by this paper
• Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism1

  2005cited by this paper
• Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia

  2004cited by this paper
• Shaping the nuclear action of NF-κB

  2004cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• Shaping the nuclear action of NF-kappaB.

  2004cited by this paper
• Adenosine: an endogenous regulator of innate immunity.

  2004cited by this paper
• Targeted Disruption of cd73/Ecto-5′-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response

  2004cited by this paper
• Normalization of cDNA microarray data.

  2003cited by this paper
• Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation

  2002cited by this paper
• A Nuclear Factor-κB Inhibitor BAY 11-7082 Suppresses Endothelin-1 Production in Cultured Vascular Endothelial Cells

  2002cited by this paper
• Innate immune recognition.

  2002cited by this paper
• A nuclear factor-kappaB inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells.

  2002cited by this paper
• Adenosine induces cyclic‐AMP formation and inhibits endothelin‐1 production/secretion in guinea‐pig tracheal epithelial cells through A2B adenosine receptors

  2000cited by this paper
• Pathophysiology of endothelin in the cardiovascular system.

  1999cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• 5'-Nucleotidase: molecular structure and functional aspects.

  1992cited by this paper
• Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.

  1972cited by this paper

• The role and therapeutic potential of purinergic signaling pathway in metabolic syndrome-related atherosclerosis

  2026cites this paper
• Lipid Metabolism Alterations in Hereditary Inorganic Pyrophosphate Deficiency Syndromes: A Narrative Review of Insights and Controversies

  2025cites this paper
• CD39 and CD73: biological functions, diseases and therapy

  2025cites this paper
• Der extrazelluläre Adenosinstoffwechsel um CD73: ein neuer Therapieansatz bei entzündungsassoziierten Gefäßerkrankungen?

  2024cites this paper
• CD73 deficiency does not aggravate angiotensin II-induced aortic inflammation in mice

  2023cites this paper
• Ticagrelor combined with aspirin displays the signature of regulating the gut microbiome in consistence with improving the immuno-inflammatory response in atherosclerosis

  2023cites this paper
• Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated Individuals

  2022cites this paper
• Subclinical Atherosclerosis is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in HIV Treated Individuals

  2022cites this paper
• ABCC6 deficiency promotes dyslipidemia and atherosclerosis

  2021cites this paper
• ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions

  2021cites this paper
• CD73 regulates hepatic stellate cells activation and proliferation through Wnt/β-catenin signaling pathway.

  2020cites this paper
• Fluorescent Probes for Ecto-5'-nucleotidase (CD73).

  2020cites this paper
• Deficiency of CD73 activity promotes protective cardiac immunity against Trypanosoma cruzi infection but permissive environment in visceral adipose tissue.

  2020cites this paper
• Biochemical analysis of ectonucleotidases on primary rat vascular smooth muscle cells and in silico investigation of their role in vascular diseases.

  2020cites this paper
• Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

  2020cites this paper
• Effect of estradiol on enzymes of vascular extracellular nucleotide metabolism

  2020cites this paper
• Nlrp 3 , Csf 3 , and Edn 1 in Macrophage Response to Saturated Fatty Acids and Modified Low-Density Lipoprotein

  2020cites this paper
• Nlrp3, Csf3, and Edn1 in Macrophage Response to Saturated Fatty Acids and Modified Low-Density Lipoprotein

  2020cites this paper
• CD73 Promotes Age-Dependent Accretion of Atherosclerosis.

  2020cites this paper
• CD73 (Cluster of Differentiation 73) and the Differences Between Mice and Humans.

  2019cites this paper
• Tumor CD73/A2aR adenosine immunosuppressive axis and tumor‐infiltrating lymphocytes in diffuse large B‐cell lymphoma: correlations with clinicopathological characteristics and clinical outcome

  2019cites this paper
• Dysregulation of ectonucleotidase-mediated extracellular adenosine during postmenopausal bone loss

  2019cites this paper
• Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia‐reperfusion injury: A prospective case‐control study

  2019cites this paper
• The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases

  2018cites this paper
• Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction

  2018cites this paper
• Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

  2018cites this paper
• Regulation of CD73 in the development of lower limb atherosclerosis

  2017cites this paper
• Novel B-cell subsets in atherosclerosis

  2016cites this paper
• Ectonucleotidases in Immunobiology

  2016cites this paper
• Effects of P2Y12 receptor antagonists beyond platelet inhibition – comparison of ticagrelor with thienopyridines

  2016cites this paper
• Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition.

  2016cites this paper
• Purinergic Signalling and Endothelium.

  2016cites this paper
• The arterial microenvironment: the where and why of atherosclerosis.

  2016cites this paper
• Correlation Between E3 SUMO-Protein Ligase NSE2 (NSMCE2) with 5'-nucleotidase, XOR, Uric acid and Total protein in Patients with Atherosclerosis

  2015cites this paper
• CD73 regulates vascular smooth muscle cell functions and facilitates atherosclerotic plaque formation

  2015cites this paper
• Mouse aorta-derived mesenchymal progenitor cells contribute to and enhance the immune response of macrophage cells under inflammatory conditions

  2015cites this paper
• The role of ecto-5′-nucleotidase in endothelial dysfunction and vascular pathologies

  2015cites this paper
• Purinergic signaling in atherosclerosis.

  2015cites this paper
• Relationship between E3 SUMO-protein Ligase NSE2 (NSMCE2) with Ecto-5'-nucleotidase, ADA and AMPDA Enzymes in Patients with Atherosclerosis

  2015cites this paper
• The role of CD73 in the pathogenesis of Juvenile Idiopathic Arthritis

  2015cites this paper
• Investigating the role of the CCL2/CCR2 axis in monocytes and its modulation by extracellular nucleotides

  2015cites this paper
• Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.

  2015cites this paper
• Purinergic Signaling and Blood Vessels in Health and Disease

  2014cites this paper
• Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities

  2014cites this paper
• Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases

  2014cites this paper
• CD 39 and CD 73 in immunity and inflammation

  2013cites this paper
• Novel effects of adenosine receptors on pericellular hyaluronan matrix: implications for human smooth muscle cell phenotype and interactions with monocytes during atherosclerosis

  2013cites this paper
• Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice

  2013cites this paper
• CD4+CD73+ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression

  2013cites this paper
• CD39 and CD73 in immunity and inflammation.

  2013cites this paper
• Targeting adenosine receptors in the development of cardiovascular therapeutics

  2012cites this paper
• CD73: a potent suppressor of antitumor immune responses.

  2012cites this paper
• Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase.

  2012cites this paper
• The Outsiders: Emerging Roles of Ectonucleotidases in Inflammation

  2012cites this paper